€3.89
4.66% today
Madrid, Apr 04, 05:35 pm CET
ISIN
ES0134950F36
Symbol
FAE
Sector
Industry

Faes Farma SAReg Target price 2025 - Analyst rating & recommendation

Faes Farma SAReg Classifications & Recommendation:

Buy
40%
Hold
40%
Sell
20%

Faes Farma SAReg Price Target

Target Price €4.15
Price €3.89
Potential
Number of Estimates 5
5 Analysts have issued a price target Faes Farma SAReg 2026 . The average Faes Farma SAReg target price is €4.15. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 2 Analysts recommend Faes Farma SAReg to buy, 2 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Faes Farma SAReg stock has an average upside potential 2026 of . Most analysts recommend the Faes Farma SAReg stock at Buy or hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million € 493.65 517.58
9.42% 4.85%
EBITDA Margin 22.84% 25.75%
2.40% 12.76%
Net Margin 22.70% 19.05%
9.67% 16.07%

3 Analysts have issued a sales forecast Faes Farma SAReg 2025 . The average Faes Farma SAReg sales estimate is

€518m
Unlock
. This is
4.85% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€530m 7.36%
Unlock
, the lowest is
€501m 1.49%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €494m 9.42%
2025
€518m 4.85%
Unlock
2026
€540m 4.25%
Unlock
2027
€582m 7.86%
Unlock

3 Analysts have issued an Faes Farma SAReg EBITDA forecast 2025. The average Faes Farma SAReg EBITDA estimate is

€133m
Unlock
. This is
3.45% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€138m 7.10%
Unlock
, the lowest is
€130m 0.82%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €113m 12.05%
2025
€133m 18.25%
Unlock
2026
€135m 1.22%
Unlock
2027
€145m 7.47%
Unlock

EBITDA Margin

2024 22.84% 2.40%
2025
25.75% 12.76%
Unlock
2026
25.00% 2.91%
Unlock
2027
24.91% 0.36%
Unlock

2 Faes Farma SAReg Analysts have issued a net profit forecast 2025. The average Faes Farma SAReg net profit estimate is

€98.6m
Unlock
. This is
11.99% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€99.6m 11.11%
Unlock
, the lowest is
€97.6m 12.87%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €112m 20.00%
2025
€98.6m 11.99%
Unlock
2026
€100m 1.71%
Unlock
2027
€107m 7.05%
Unlock

Net Margin

2024 22.70% 9.67%
2025
19.05% 16.07%
Unlock
2026
18.59% 2.41%
Unlock
2027
18.45% 0.75%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share 0.36 0.32
20.00% 11.11%
P/E 12.88
EV/Sales 2.33

2 Analysts have issued a Faes Farma SAReg forecast for earnings per share. The average Faes Farma SAReg EPS is

€0.32
Unlock
. This is
11.11% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€0.32 11.11%
Unlock
, the lowest is
€0.31 13.89%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €0.36 20.00%
2025
€0.32 11.11%
Unlock
2026
€0.32 0.00%
Unlock
2027
€0.35 9.38%
Unlock

P/E ratio

Current 11.40 7.65%
2025
12.88 12.98%
Unlock
2026
12.66 1.71%
Unlock
2027
11.83 6.56%
Unlock

Based on analysts' sales estimates for 2025, the Faes Farma SAReg stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.44 17.31%
2025
2.33 4.48%
Unlock
2026
2.24 4.08%
Unlock
2027
2.07 7.29%
Unlock

P/S ratio

Current 2.57 18.57%
2025
2.45 4.63%
Unlock
2026
2.35 4.08%
Unlock
2027
2.18 7.28%
Unlock

Current Faes Farma SAReg Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
CAIXABANK BPI
Locked
Locked
Locked Sep 22 2024
NORBOLSA
Locked
Locked
Locked Sep 19 2024
Analyst Rating Date
Locked
CAIXABANK BPI:
Locked
Locked
Sep 22 2024
Locked
NORBOLSA:
Locked
Locked
Sep 19 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today